Berenberg upgraded Eli Lilly (LLY) to buy from hold and boosted its price target to $1,400 from $1,220 as the healthcare giant extends its lead over Novo (NVO). Rick Ducat stacks the stock against its peers and shows how bulls can regain momentum in the stock following a slowdown in recent sessions. He turns to an example options trade for Eli Lilly.